Cargando…
1097. A Prospective Evaluation of SARS-CoV-2 Shedding and Evolution in Immunocompromised Hosts During the Omicron Period — IVY Network, 5 U.S. States, April 11, 2022 – February 1, 2023
BACKGROUND: Prolonged SARS-CoV-2 infections in immunocompromised hosts may predict or source the emergence of highly mutated variants of concern. The types of immunosuppression placing patients at highest risk for prolonged infection and associated intra-host viral evolution remain unclear. [Figure:...
Autores principales: | Raglow, Zoe M, Surie, Diya, Chappell, James, Zhu, Yuwei, Martin, Emily T, Kwon, Jennie H, Frosch, Anne, Mohamed, Amira, Gilbert, Julie, Bendall, Emily E, Bahr, Auden, Halasa, Natasha B, Talbot, H Keipp, Grijalva, Carlos G, Baughman, Adrienne, Womack, Kelsey N, Johnson, Cassandra, Swan, Sydney A, Burroughs, Ashley, Koumans, Emilia, McMorrow, Meredith L, Harcourt, Jennifer L, Atherton, Lydia J, Thornburg, Natalie J, Self, Wesley, Lauring, Adam S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678486/ http://dx.doi.org/10.1093/ofid/ofad500.070 |
Ejemplares similares
-
SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
por: Raglow, Zoe, et al.
Publicado: (2023) -
2083. Waning of Bivalent mRNA Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years – IVY Network, 20 U.S. States, September 8, 2022-April 1, 2023
por: DeCuir, Jennifer, et al.
Publicado: (2023) -
1108. Severity of Illness among Adults Hospitalized with Respiratory Syncytial Virus Compared with COVID-19 and Influenza — IVY Network, 25 Hospitals, 20 U.S. States, January 31, 2022 – April 11, 2023
por: Yuengling, Katharine, et al.
Publicado: (2023) -
Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report—IVY Network, February 1–August 31, 2022
por: Surie, Diya, et al.
Publicado: (2023) -
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
por: Surie, Diya, et al.
Publicado: (2022)